-
1
-
-
0842303167
-
Autoantibodies to protein transport and messenger RNA processing pathways: Endosomes, lysosomes, Golgi complex, proteasomes, assemblyomes, exosomes, and GW bodies
-
Stinton LM, Eystathioy T, Selak S, Chan EDL, Fritzler MJ. Autoantibodies to protein transport and messenger RNA processing pathways: endosomes, lysosomes, Golgi complex, proteasomes, assemblyomes, exosomes, and GW bodies. Clin Immunol 2004 110 : 30 44.
-
(2004)
Clin Immunol
, vol.110
, pp. 30-44
-
-
Stinton, L.M.1
Eystathioy, T.2
Selak, S.3
Chan, E.D.L.4
Fritzler, M.J.5
-
2
-
-
0030850669
-
Proteasome inhibitors and antigen presentation
-
Bogyo M, Gaczynska M, Ploegh HL. Proteasome inhibitors and antigen presentation. Biopoly 1997 43 : 269 80.
-
(1997)
Biopoly
, vol.43
, pp. 269-80
-
-
Bogyo, M.1
Gaczynska, M.2
Ploegh, H.L.3
-
3
-
-
0036789781
-
Significance of increased circulating proteasome in autoimmune disease
-
Mountz JD. Significance of increased circulating proteasome in autoimmune disease. J Rheumatol 2002 29 : 2027 30.
-
(2002)
J Rheumatol
, vol.29
, pp. 2027-30
-
-
Mountz, J.D.1
-
4
-
-
0036790834
-
Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases
-
Egerer K, Kuckelkorn U, Rudolph PE et al. Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases. J Rheumatol 2002 29 : 2045 52.
-
(2002)
J Rheumatol
, vol.29
, pp. 2045-52
-
-
Egerer, K.1
Kuckelkorn, U.2
Rudolph, P.E.3
-
5
-
-
40849104329
-
The functional role of proteasome antibodies in neurological disorders
-
In: Di Napoli, M., Wojcik, C., eds. Hauppauge, NY: Nova Science Publishers (. in press).
-
Storstein S, Vedeler C. The functional role of proteasome antibodies in neurological disorders. In : Di Napoli M, Wojcik C, eds. The UPS in Nervous System: From Physiology to Pathology. Hauppauge, NY : Nova Science Publishers (in press).
-
The UPS in Nervous System: From Physiology to Pathology.
-
-
Storstein, S.1
Vedeler, C.2
-
6
-
-
0029952778
-
Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemiclupus erythematosus
-
Feist E, Dorner T, Kuckelkorn U et al. Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemiclupus erythematosus. J Exp Med 1996 184 : 1313 8.
-
(1996)
J Exp Med
, vol.184
, pp. 1313-8
-
-
Feist, E.1
Dorner, T.2
Kuckelkorn, U.3
-
7
-
-
35649006958
-
Autoantibodies to the proteasome in monosymptomatic optic neuritis may predict progression to multiple sclerosis
-
Beyer NH, Milthers J, Bonde A-M et al. Autoantibodies to the proteasome in monosymptomatic optic neuritis may predict progression to multiple sclerosis. S J Clin Lab Invest 2007 67 : 696 706.
-
(2007)
S J Clin Lab Invest
, vol.67
, pp. 696-706
-
-
Beyer, N.H.1
Milthers, J.2
Bonde, A.-M.3
-
8
-
-
22144471854
-
Proteasome antibodies in paraneoplastic cerebellar degeneration
-
Storstein A, Knudsen A, Vedeler CA. Proteasome antibodies in paraneoplastic cerebellar degeneration. J Neuroimmunol 2005 165 : 172 8.
-
(2005)
J Neuroimmunol
, vol.165
, pp. 172-8
-
-
Storstein, A.1
Knudsen, A.2
Vedeler, C.A.3
-
9
-
-
33645731530
-
Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosis
-
Bazzaro M, Lee MK, Zoso A et al. Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosis. Cancer Res 2006 66 : 3754 63.
-
(2006)
Cancer Res
, vol.66
, pp. 3754-63
-
-
Bazzaro, M.1
Lee, M.K.2
Zoso, A.3
-
10
-
-
18944403669
-
High plasma proteasome levels are detected in patients with metastatic malignant melanoma
-
Stoebner PE, Lavabre-Bertrand T, Henry L et al. High plasma proteasome levels are detected in patients with metastatic malignant melanoma. Br J Dermatol 2005 152 : 948 53.
-
(2005)
Br J Dermatol
, vol.152
, pp. 948-53
-
-
Stoebner, P.E.1
Lavabre-Bertrand, T.2
Henry, L.3
-
11
-
-
1542608360
-
Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer
-
Monstad SE, Drivsholm L, Storstein A et al. Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer. J Clin Oncol 2004 22 : 795 800.
-
(2004)
J Clin Oncol
, vol.22
, pp. 795-800
-
-
Monstad, S.E.1
Drivsholm, L.2
Storstein, A.3
-
12
-
-
33745626144
-
Ri antibodies in patients with breast, ovarian, or small cell lung cancer determined by a sensitive immunoprecipitation technique
-
Knudsen A, Monstad SE, Dørum A et al. Ri antibodies in patients with breast, ovarian, or small cell lung cancer determined by a sensitive immunoprecipitation technique. Cancer Immunol Immunother 2006 55 : 1280 4.
-
(2006)
Cancer Immunol Immunother
, vol.55
, pp. 1280-4
-
-
Knudsen, A.1
Monstad, S.E.2
Dørum, A.3
-
13
-
-
36349030247
-
CRMP5 antibodies in patients with small-cell lung cancer ot thymoma
-
[Epub ahead of print].
-
Monstad SE, Drivsholm L, Skeie GO et al. CRMP5 antibodies in patients with small-cell lung cancer ot thymoma. Cancer Immunol Immunother 2008 57 : 227 32 [Epub ahead of print].
-
(2008)
Cancer Immunol Immunother
, vol.57
, pp. 227-32
-
-
Monstad, S.E.1
Drivsholm, L.2
Skeie, G.O.3
-
14
-
-
0036895612
-
The proteasome is a major autoantigen in multiple sclerosis
-
Mayo I, Arribas J, Villoslada P et al. The proteasome is a major autoantigen in multiple sclerosis. Brain 2002 125 : 2658 67.
-
(2002)
Brain
, vol.125
, pp. 2658-67
-
-
Mayo, I.1
Arribas, J.2
Villoslada, P.3
-
15
-
-
0026011789
-
Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus
-
Arribas J, Luz Rodriguez M, Alvarez-Do Forno R, Castano JG. Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus. J Exp Med 1991 173 : 423 7.
-
(1991)
J Exp Med
, vol.173
, pp. 423-7
-
-
Arribas, J.1
Luz Rodriguez, M.2
Alvarez-Do Forno, R.3
Castano, J.G.4
-
16
-
-
0032588690
-
Autoantibodies in primary Sjögren's syndrome are directed against proteasomal subunits of the alpha and beta type
-
Feist E, Kuckelkorn U, Dorner T et al. Autoantibodies in primary Sjögren's syndrome are directed against proteasomal subunits of the alpha and beta type. Arthritis Rheum 1999 42 : 697 702.
-
(1999)
Arthritis Rheum
, vol.42
, pp. 697-702
-
-
Feist, E.1
Kuckelkorn, U.2
Dorner, T.3
-
17
-
-
4344639685
-
Prevalence of 20S proteasome, anti-nuclear and thyroid antibodies in young patients at onset of type 1 diabetes mellitus and the risk of autoimmune thyroiditis
-
Kordonouri O, Meyer K, Egerer K et al. Prevalence of 20S proteasome, anti-nuclear and thyroid antibodies in young patients at onset of type 1 diabetes mellitus and the risk of autoimmune thyroiditis. J Pediatr Endocrinol Metab 2004 17 : 975 81.
-
(2004)
J Pediatr Endocrinol Metab
, vol.17
, pp. 975-81
-
-
Kordonouri, O.1
Meyer, K.2
Egerer, K.3
-
18
-
-
0033806263
-
Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis
-
Mayo I, Arizti P, Pares A et al. Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis. J Hepatol 2000 33 : 528 36.
-
(2000)
J Hepatol
, vol.33
, pp. 528-36
-
-
Mayo, I.1
Arizti, P.2
Pares, A.3
-
19
-
-
0036481263
-
Epitope spreading in immune-mediated diseases: Implications for immunotherapy
-
Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol 2002 2 : 85 95.
-
(2002)
Nat Rev Immunol
, vol.2
, pp. 85-95
-
-
Vanderlugt, C.L.1
Miller, S.D.2
-
20
-
-
0742270419
-
Autoimmune response to proteasome activator 28 alpha in patients with connective tissue diseases
-
Matsushita M, Takasaki Y, Takeuchi K, Yamada H, Matsudaira R, Hashimoto H. Autoimmune response to proteasome activator 28 alpha in patients with connective tissue diseases. J Rheumatol 2004 31 : 252 9.
-
(2004)
J Rheumatol
, vol.31
, pp. 252-9
-
-
Matsushita, M.1
Takasaki, Y.2
Takeuchi, K.3
Yamada, H.4
Matsudaira, R.5
Hashimoto, H.6
|